Lataa...
microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance
Lung cancer is considered the most deadly of all cancers, with limited therapeutic options. Although advanced drugs have been tried in clinic, the therapeutic success has largely been hampered due to rapid development of drug-resistance mechanisms. Recently, microRNAs (miRNAs), a class of small non-...
Tallennettuna:
Julkaisussa: | Front Med (Lausanne) |
---|---|
Päätekijät: | , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Frontiers Media S.A.
2015
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4631988/ https://ncbi.nlm.nih.gov/pubmed/26583081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2015.00077 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|